Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck
Go back to Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On DeckHalozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 38.46 -0.66 (1.69%) | |||||
---|---|---|---|---|---|---|
Previous Close | $39.12 | 52 Week High | $18.39 | |||
Open | $38.71 | 52 Week Low | $6.96 | |||
Day High | $38.75 | P/E | N/A | |||
Day Low | $38.23 | EPS | $-0.58 | |||
Volume | 693,350 |
Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 724.87 -7.33 (1%) | |||||
---|---|---|---|---|---|---|
Previous Close | $732.20 | 52 Week High | $88.16 | |||
Open | $725.00 | 52 Week Low | $67.88 | |||
Day High | $727.99 | P/E | 167.79 | |||
Day Low | $718.30 | EPS | $4.32 | |||
Volume | 2,608,539 |
Medtronic Inc. (NYSE: MDT) | Delayed: 79.25 -1.13 (1.41%) | |||||
---|---|---|---|---|---|---|
Previous Close | $80.38 | 52 Week High | $89.27 | |||
Open | $80.04 | 52 Week Low | $71.03 | |||
Day High | $80.35 | P/E | 22.51 | |||
Day Low | $78.78 | EPS | $3.52 | |||
Volume | 5,624,096 |
NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 125.79 -0.37 (0.29%) | |||||
---|---|---|---|---|---|---|
Previous Close | $126.16 | 52 Week High | $59.00 | |||
Open | $123.69 | 52 Week Low | $32.80 | |||
Day High | $125.85 | P/E | N/A | |||
Day Low | $123.21 | EPS | $0.00 | |||
Volume | 3,433,874 |
SANOFI (NASDAQ: SNY) | Delayed: 49.36 +2.75 (5.90%) | |||||
---|---|---|---|---|---|---|
Previous Close | $46.61 | 52 Week High | $44.76 | |||
Open | $48.80 | 52 Week Low | $36.81 | |||
Day High | $49.83 | P/E | N/A | |||
Day Low | $48.65 | EPS | $0.00 | |||
Volume | 6,469,821 |